656 related articles for article (PubMed ID: 17714422)
21. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study.
Lapierre V; Aupérin A; Robinet E; Ferrand C; Oubouzar N; Tramalloni D; Saas P; Debaene B; Lasser P; Tiberghien P
Transfusion; 2007 Sep; 47(9):1691-9. PubMed ID: 17725736
[TBL] [Abstract][Full Text] [Related]
22. Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases.
Cid J; Lozano M; Fernández-Avilés F; Carreras E; Pereira A; Mazzara R; Ordinas A
Transfusion; 2006 Feb; 46(2):169-73. PubMed ID: 16441590
[TBL] [Abstract][Full Text] [Related]
23. Red cell immunization in multiply transfused Malay thalassemic patients.
Noor Haslina MN; Ariffin N; Illuni Hayati I; Rosline H
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1015-20. PubMed ID: 17333748
[TBL] [Abstract][Full Text] [Related]
24. Non-D Rh antibodies appearing after apheresis platelet transfusion: stimulation by red cells or microparticles?
Kitazawa J; Nollet K; Morioka H; Tanaka K; Inomata M; Kubuki Y; Ohto H
Vox Sang; 2011 May; 100(4):395-400. PubMed ID: 21029111
[TBL] [Abstract][Full Text] [Related]
25. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin.
Nester TA; Rumsey DM; Howell CC; Gilligan DM; Drachman JG; Maier RV; Kyles DM; Matthews DC; Pendergrass TW
Transfusion; 2004 Dec; 44(12):1720-3. PubMed ID: 15584986
[TBL] [Abstract][Full Text] [Related]
26. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
[TBL] [Abstract][Full Text] [Related]
27. Maternal red blood cell alloimmunisation in south western Uganda.
Natukunda B; Mugyenyi G; Brand A; Schonewille H
Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
[TBL] [Abstract][Full Text] [Related]
28. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.
Tournamille C; Meunier-Costes N; Costes B; Martret J; Barrault A; Gauthier P; Galactéros F; Nzouékou R; Bierling P; Noizat-Pirenne F
Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340
[TBL] [Abstract][Full Text] [Related]
29. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis.
Shukla JS; Chaudhary RK
Indian J Pathol Microbiol; 1999 Jul; 42(3):299-302. PubMed ID: 10862287
[TBL] [Abstract][Full Text] [Related]
30. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
[TBL] [Abstract][Full Text] [Related]
31. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients.
Saied DA; Kaddah AM; Badr Eldin RM; Mohaseb SS
J Pediatr Hematol Oncol; 2011 Aug; 33(6):409-14. PubMed ID: 21792035
[TBL] [Abstract][Full Text] [Related]
32. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
[TBL] [Abstract][Full Text] [Related]
33. Passenger lymphocyte syndrome with or without immune hemolytic anemia in all Rh-positive recipients of lungs from rhesus alloimmunized donors: three new cases and a review of the literature.
Cserti-Gazdewich CM; Waddell TK; Singer LG; Chaparro C; Pendergrast JM; Hawes J; denHollander N; Tinckam K; Keshavjee S
Transfus Med Rev; 2009 Apr; 23(2):134-45. PubMed ID: 19304114
[TBL] [Abstract][Full Text] [Related]
34. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation.
Perseghin P; Balduzzi A; Galimberti S; Dassi M; Baldini V; Valsecchi MG; Pioltelli P; Bonanomi S; Faccini P; Rovelli A; Pogliani EM; Uderzo C
Bone Marrow Transplant; 2003 Jul; 32(2):231-6. PubMed ID: 12838290
[TBL] [Abstract][Full Text] [Related]
35. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.
Asfour M; Narvios A; Lichtiger B
MedGenMed; 2004 Jul; 6(3):22. PubMed ID: 15520646
[TBL] [Abstract][Full Text] [Related]
36. Intensive red blood cell transfusions and risk of alloimmunization.
Zalpuri S; Middelburg RA; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG; Zwaginga JJ
Transfusion; 2014 Feb; 54(2):278-84. PubMed ID: 23782244
[TBL] [Abstract][Full Text] [Related]
37. Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG.
Ayache S; Herman JH
Transfusion; 2008 Sep; 48(9):1990-9. PubMed ID: 18564395
[TBL] [Abstract][Full Text] [Related]
38. Storage time of transfused red blood cells and impact on clinical outcomes in hematopoietic stem cell transplantation.
Kekre N; Chou A; Tokessey M; Doucette S; Tinmouth A; Tay J; Allan DS
Transfusion; 2011 Nov; 51(11):2488-94. PubMed ID: 21569047
[TBL] [Abstract][Full Text] [Related]
39. [Detection and analysis of anti-Rh blood group antibodies].
Wu YJ; Wu Y; Chen BC; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):604-6. PubMed ID: 18538092
[TBL] [Abstract][Full Text] [Related]
40. Incidence of Rh anti-E and anti-c production among Japanese after blood transfusion.
Komatsu F
Bull Tokyo Med Dent Univ; 1988 Sep; 35(3):75-9. PubMed ID: 3148374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
